These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1701 related items for PubMed ID: 16575428

  • 1. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH, Andersen HF, Thase ME.
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [Abstract] [Full Text] [Related]

  • 4. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ, Ventura D, Chang CC.
    J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
    [Abstract] [Full Text] [Related]

  • 5. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA, Andersen HF.
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [Abstract] [Full Text] [Related]

  • 6. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 7. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR, Arikian SR, Casciano J, Doyle JJ.
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [Abstract] [Full Text] [Related]

  • 8. [Escitalopram for treatment of major depressive disorder in adults].
    Llorca PM, Brousse G, Schwan R.
    Encephale; 2005 Feb; 31(4 Pt 1):490-501. PubMed ID: 16389716
    [Abstract] [Full Text] [Related]

  • 9. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
    Llorca PM, Fernandez JL.
    Int J Clin Pract; 2007 Apr; 61(4):702-10. PubMed ID: 17394446
    [Abstract] [Full Text] [Related]

  • 10. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P.
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [Abstract] [Full Text] [Related]

  • 11. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K, Perry CM.
    CNS Drugs; 2001 Feb; 15(8):643-69. PubMed ID: 11524036
    [Abstract] [Full Text] [Related]

  • 12. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW, Lönn SL, Despiégel N.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [Abstract] [Full Text] [Related]

  • 13. Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.
    Kornstein SG, Li D, Mao Y, Larsson S, Andersen HF, Papakostas GI.
    CNS Spectr; 2009 Jun; 14(6):326-33. PubMed ID: 19668123
    [Abstract] [Full Text] [Related]

  • 14. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
    Kaplan EM.
    Clin Ther; 2002 Jul; 24(7):1194-200. PubMed ID: 12182262
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA, Hanwella R.
    Int Clin Psychopharmacol; 2012 Jan; 27(1):8-16. PubMed ID: 21971532
    [Abstract] [Full Text] [Related]

  • 17. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM, Llorca PM, Despiegel N, Verpillat P.
    Encephale; 2004 Jan; 30(2):158-66. PubMed ID: 15107719
    [Abstract] [Full Text] [Related]

  • 18. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
    Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.
    Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
    [Abstract] [Full Text] [Related]

  • 19. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH.
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [Abstract] [Full Text] [Related]

  • 20. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
    Wang G, Gislum M, Filippov G, Montgomery S.
    Curr Med Res Opin; 2015 Apr; 31(4):785-94. PubMed ID: 25650503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.